Delivery Order 36F79718D0403-36C26025F0129
Award Date
1/20/25
Potential Completion Date
9/30/25
Potential Value
$112K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Daiichi Sankyo, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Daiichi Sankyo, Inc., a pharmaceutical manufacturer, for the supply of the drug pexidartinib (marketed as TURALIO) in 125mg capsules. The contract, valued at $73,651.68, was awarded under the VA's National Acquisition Center Blanket Purchase Agreement (BPA) for the GSA Pharmaceuticals and Drugs Schedule. This unrestricted BPA enables VA locations nationwide to procure the drug as needed to...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 20 to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $27,913.44 order was placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has an ultimate completion date of August 19, 2024. The order is for the delivery of emergency pharmaceutical products,...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $27,913.44 firm-fixed-price delivery order to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The order is for the oncology medication ICLUSIG 15MG TABS under Takeda's existing General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. This delivery order is part of a larger $13 million single-award...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of ICLUSIG 15 mg, an oncology medication, to VA medical facilities and Veterans Integrated Service Networks (VISNs) across multiple regions. The contract is a firm-fixed-price delivery order under Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals...
This federal contract award is for the delivery of the oncology medication ICLUSIG (ponatinib) to the U.S. Department of Veterans Affairs (VA). The prime contractor is Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $14,197.39 and is a firm-fixed-price delivery order under Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. It supports the VA's Veterans Integrated Service...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract, valued at $13,956.72, is for the delivery of ICLUSIG 10 & 15 MG, a specialty oncology medication, to various VA medical facilities across the country. The contract was awarded against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals...
The Department of Veterans Affairs Veterans Health Administration awarded a $14,330.88 delivery order contract to Takeda Pharmaceuticals America, Inc. for the pharmaceutical ICLUSIG 30 MG. Takeda Pharmaceutical Company LIMITED is the parent company of the prime contractor. The contract was awarded against Takeda's Pharmaceuticals and Drugs GSA Schedule contract and will be performed in Earth City, Missouri over a four-day period from September 26-29, 2023. As the contract was awarded on a firm...
This federal contract award is for ICLUSIG 30MG TAB (NDC: 63020-0533-30), a specialty pharmaceutical product, to the Department of Veterans Affairs Veterans Health Administration. The prime contractor is Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract has a firm fixed price of $14,490.39 and a completion date of March 18, 2024. It was awarded under Takeda's General Services Administration (GSA) Schedule 61-IB for...
This federal contract award is for the supply of emergency medication to the Department of Veterans Affairs (VA) Syracuse Medical Center, specifically for the Veterans Integrated Service Network (VISN) 2 region. The contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. Takeda Pharmaceuticals America is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, based in Japan. The...
The Department of Veterans Affairs Veterans Health Administration awarded a $14,330.88 delivery order contract to Takeda Pharmaceuticals America, Inc. for the pharmaceutical ICLUSIG 30 MG. Takeda Pharmaceuticals America is a subsidiary of Takeda Pharmaceutical Company LIMITED and will supply the product under GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB). Performance will take place in Earth City, Missouri over a period of five days from October 26 to October 30, 2023. The fixed-price...